a significant trendP <0.001
Mixed-effects model analysis of MI vs breast cancer development stage showed a significant trend for increasing levels of methylation of all four biomarkers during progression from benign towards malignant ( P <0.001 for trend by both categorical and linear mixed-effects model) ( Figure 3 ).